Back to News
Market Impact: 0.22

Morgan Stanley initiates Honeywell Aerospace stock at equalweight

Company FundamentalsAnalyst EstimatesCompany FundamentalsCorporate Guidance & OutlookTechnology & Innovation
Morgan Stanley initiates Honeywell Aerospace stock at equalweight

Morgan Stanley initiated coverage on Honeywell Aerospace (HONA) with an Equalweight rating and a $255 target vs. $238.14 current price, implying upside, while InvestingPro flags potential overvaluation versus fair value. The standalone aerospace/defense supplier has LTM revenue of $17.7B and EBITDA of $3.9B (per Q1 2026 data), with an end-market mix of ~44% commercial aftermarket, 41% defense/space, and 15% commercial OEM. Initial analyst stances are largely cautious (multiple Holds), with the stock up about 7% on its Nasdaq debut.

Analysis

The market is likely underestimating how much of the standalone rerating story is already in the price. A clean aerospace pure-play can command a premium only if management proves that R&D reuse converts into faster program wins and better cash conversion; otherwise investors will eventually treat it like a high-quality industrial with limited organic growth, and the multiple can drift back toward the high-teens EV/EBITDA range.

The bigger second-order risk is not today’s earnings but the next two quarters of order visibility. A sustained oil shock can bite commercial aftermarket with a lag as airlines reduce utilization before they cut maintenance budgets, so the P&L can stay resilient while the forward book softens 1-2 quarters later. Defense/space should cushion that, but it also means the stock’s downside is more about multiple compression than near-term profit collapse.

Consensus appears to be missing that this is now a relative-value name versus GE Aerospace, RTX, and TransDigm rather than a pure spin-off novelty. If standalone SG&A and separation costs are heavier than modeled, or if the first post-separation guide implies lower FCF conversion, the premium case weakens quickly. The contrarian risk/reward is therefore asymmetric: good execution may hold the stock near fair value, but any miss on margin/FCF could reset expectations for 6-18 months.

More News